Abstract
The design, synthesis, and structure–activity relationship of two novel classes of benzoxazine derivatives with dual selective serotonin reuptake inhibitors and 5-HT 1A receptor activities are described.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have